Introduction: The World Health Organization 2017 report shows that 325 million people are infected by HBV or HCV. Therefore, Tests and Counseling Centers are already done screening tests and diagnosis of hepatitis, for places in which care is primarily for those who are at greater risk of infection and populations in situations of vulnerability. Methodology: Observational, descriptive and analytical study using data from electronic and physical records of patients treated at CEDAP in 2017 diagnosed with Hepatitis B and / or C. Results: There were 124 HBV and 90 HCV carriers among 6,319 individuals. There was predominance of males with HBV. The transmission route for both was significant, being 76.1% by sex in HBV and 53.3% by way unknown in HCV. Coinfection with HIV was 47.6% with HBV and 35.5% with HCV. And drug use was higher in the HCV group (p <0.001). Discussion: The prevalence was higher than in the population without increased risk, but it resembled that found in drug users and other CTAs. Epidemiological data, such as sex, age and ethnicity corroborate with that found in general populations. Conclusion: The prevalence of B and C virus and the co-infection with HIV in CTA in 2017 were high, male, brown, and Salvador-Bahia origin predominated. Co-infection between HBV, HCV and HIV was significant, as was the use of drugs in these groups